Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Dividend growth and low payout ratios are key for long-term compounding. Click here for more information on Dividend ...

How many shares of Pfizer should you own to make $10,000 in annual dividend income? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy ...

Once Pfizer's pipeline efforts yield fruit, it is expected to have solid revenue, earnings, and dividend growth for a long time. Pfizer may be down, but it's not out yet. Income investors willing ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Markets expect ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

Investors love dividend stocks, especially the high-yield variety ... the past two years as many people are not getting boosters. Pfizer Inc. (NYSE: PFE) discovers, develops, manufactures ...

Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to ...

Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to ...